Most recents (4)

jeevan patwa

@jeevanpatwa

#Lauruslab What went wrong

ARV formulations was 1500 cr business for Laurus, they didn't participate in tenders in Q1 at lower pricing thinking that would have impacted long term margins for entire 1500 crs. Q2 pricing went down further. Took them 2 qtrs to adjust to this..

People say it couldn't deliver on promise. It has actually delivered fantasticaly on nonARV, CDMO.

ARV is where it went wrong and that was because of change in business dynamics similar to what happened in US generics few years back. Players are still not able to adjust to that

On brighter side, it spent 1300 crs in last 18 months and will be spending similar in next 18 months. So effectively gross block will double from Mar'21 to Mar'24 and majority of that is towards nonARV and CDMO funded through internal accrual

Read 5 tweets

@kach0289

someone asked me today - what to do with #lauruslab?
I asked what to do as in?
If u invested by seeing something in stock and If those fundamental things haven't changed, this question seems absurd to me.
Then I got typical reply which I was anyway expecting-

"I think u haven't seen Price recently"
My response was - yes I have seen it and price has corrected well and will definitely hurt them who bought for short term + on a level which was not right as per charts.
so again I had to explain him this after so many obvious question

when u buy any stock by seeing Price movement - It means u are trying to chase Momentum and when you are trying to chase momentum - u must use BASIC Price action to get ur SL - as your view is short term and in short term price play can be ugly.

Read 17 tweets